Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2014
Context: The filing announces the scheduled release of financial results for the quarter ended September 30, 2014.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of an upcoming earnings announcement.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document contains no comparative data versus prior periods.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: After 5:00 pm ET on November 11, 2014.
- Conference Call: Scheduled for November 12, 2014, to review third-quarter 2014 financial results.
- Exhibits: A press release dated October 29, 2014, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results released on November 11, 2014, as this 8-K contains no numerical data.
- Review the conference call transcript from November 12, 2014, for management commentary on Q3 2014 performance.
- Confirm the company's cash position and burn rate in the subsequent 10-Q filing for the quarter ended September 30, 2014.